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Abstract
Background: Accumulated evidence shows that the ACE-AngII-AT1 axis of the renin-angiotensin system (RAS) is markedly
activated in chronic heart failure (CHF). Recent studies provide information that Angiotensin (Ang)-(1–7), a metabolite of
AngII, counteracts the effects of AngII. However, this balance between AngII and Ang-(1–7) is still little understood in CHF.
We investigated the effects of exercise training on circulating and skeletal muscle RAS in the ischemic model of CHF.
Methods/Main Results: Male Wistar rats underwent left coronary artery ligation or a Sham operation. They were divided
into four groups: 1) Sedentary Sham (Sham-S), 2) exercise-trained Sham (Sham-Ex), sedentary CHF (CHF-S), and exercise-
trained CHF (CHF-Ex). Angiotensin concentrations and ACE and ACE2 activity in the circulation and skeletal muscle (soleus
and plantaris) were quantified. Skeletal muscle ACE and ACE2 protein expression, and AT1, AT2, and Mas receptor gene
expression were also evaluated. CHF reduced ACE2 serum activity. Exercise training restored ACE2 and reduced ACE activity
in CHF. Exercise training reduced plasma AngII concentration in both Sham and CHF rats and increased the Ang-(1–7)/AngII
ratio in CHF rats. CHF and exercise training did not change skeletal muscle ACE and ACE2 activity and protein expression.
CHF increased AngII levels in both soleus and plantaris muscle, and exercise training normalized them. Exercise training
increased Ang-(1–7) in the plantaris muscle of CHF rats. The AT1 receptor was only increased in the soleus muscle of CHF
rats, and exercise training normalized it. Exercise training increased the expression of the Mas receptor in the soleus muscle
of both exercise-trained groups, and normalized it in plantaris muscle.
Conclusions: Exercise training causes a shift in RAS towards the Ang-(1–7)-Mas axis in skeletal muscle, which can be
influenced by skeletal muscle metabolic characteristics. The changes in RAS circulation do not necessarily reflect the
changes occurring in the RAS of skeletal muscle.
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Introduction
Increased renin angiotensin system (RAS) has been consistently
documented in chronic heart failure (CHF). Plasma Angiotensin
(Ang) II levels are increased in CHF [1–4]. Likewise, RAS
elevation in the heart, kidneys, and brain has been reported in
CHF [5–8]. This scenario shows that CHF is characterized by
overall RAS activation.
The classic RAS cascade depends on ACE-mediated conversion
of AngI into AngII, an octapeptide binding to AT1 receptor. This
ACE-AngII-AT1 axis contributes to cardiac remodeling [5,9],
high sympathetic activity [7,10], and impaired vasodilation [11] in
CHF. In addition, RAS exacerbation plays a role in skeletal
myopathy, including reactive oxygen species generation, protein
degradation, and apoptosis [12–14]. Recent studies provide
evidence of an endogenous RAS axis that counterbalances the
ACE-AngII-AT1 effects. ACE2, an ACE homolog enzyme
[15,16], metabolizes AngII into the heptapeptide Ang-(1–7) [17],
which in turn binds to the Mas receptor [18]. This ACE2-Ang-(1–
7)-Mas axis causes vasodilation and improves skeletal muscle
metabolism [19,20]. In addition, ACE2-Ang-(1–7)-Mas axis has
antifibrotic and antiapoptotic properties, opposing the deleterious
effects of ACE-AngII-AT1 overactivity [21].
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Previous studies have shown that exercise training is a
remarkable strategy in the treatment of CHF. This therapy
reduces sympathetic nerve activity and vasoconstriction [22,23]. In
addition, exercise training significantly increases exercise tolerance
and quality of life in CHF patients [24]. Effects of exercise training
on RAS have also been reported. Exercise training reduces plasma
AngII levels [10,25]. In the cardiac muscle, exercise reduces ACE
concentration, which may contribute to the reduction in
hypertrophy and collagen deposition in rats with myocardial
infarction [5]. More recently, we found a decrease in ACE and
AngII concentrations and an increase in ACE2 and Ang-(1–7)
concentration in cardiac muscle in exercise-trained rats [26]. In
addition, exercise training has been shown to increase cardiac
Ang-(1–7) in spontaneous hypertensive rats [27] and to normalize
brain ACE and ACE2 expression in CHF rabbits [7]. However,
the effects of exercise training on RAS in skeletal muscle are
unknown.
To improve the understanding regarding the role of exercise
training on circulating and skeletal muscle RAS, we investigated
the effects of exercise training on ACE-AngII-AT1 and ACE2-
Ang-(1–7)-Mas axis in rats with CHF. Our hypotheses were that:
1) Exercise training would shift the balance of RAS towards the
ACE2-Ang-(1–7)-Mas axis; 2) The changes in skeletal muscle RAS
would be independent of those observed in the circulation; and 3)
The effects of exercise training on skeletal muscle would be
influenced by muscle metabolic characteristic.
Methods
Animals
Two-month-old, male, Wistar rats from the Multidisciplinary
Center for Biological Investigation on Laboratory Animal Science
(CEMIB), University of Campinas, underwent surgical occlusion
of the main descending branch of the left coronary artery or
fictitious myocardial infarction (Sham). After a 4-week period, they
were subdivided into four groups: 1) Sedentary sham-operated
(Sham-S, n= 10); 2) exercise-trained sham-operated (Sham-Ex,
n = 10), 3) sedentary chronic heart failure (CHF-S, n= 12); and 4)
exercise-trained chronic heart failure (CHF-Ex, n= 12). Then,
basal echocardiography was performed and peak oxygen con-
sumption was measured. Finally, exercise training or follow-up
began (Experimental protocol, Fig. 1). The rats were kept 3–4 per
cage in a temperature-controlled room with a 12:12-hour light-
dark cycle. They were fed with a standard laboratory diet and
water ad libitum. The study was approved by the Scientific
Committee of the Heart Institute (InCor-HCFMUSP) and Ethical
Committee for Research Protocols of the University of Sa˜o Paulo
Medical School (CAPPesq 149/09). The study was carried out in
accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of
Health, USA. The surgery and echocardiography was performed
under anesthesia, and all efforts were made to minimize suffering.
Myocardial Infarction Induction
The rats were anesthetized with a single injection of ketamine
(50 mg.kg21 body weight, Parke-Davis) and xylazine (10 mg.kg21
body weight, Bayer). Then, the heart was exposed through a left
intercostal thoracotomy. The left coronary artery was looped by a
single nylon suture (7-0) ,1 mm. The main descending branch
was permanently occluded, which resulted in myocardial infarc-
tion and, subsequently, CHF. Finally, the heart was quickly
repositioned into the chest [28].
Cardiac Function Assessment
The left ventricular evaluations were performed in anesthetized
rats at baseline (4 weeks after surgery) and at the end of study (12
weeks after surgery). Echocardiographic studies were performed
with Acuson equipment (Siemens, Mountain View, CA, EUA)
with a 13 MHz transducer. Left ventricular dimensions were
measured in the M-mode, and left ventricular fractional shorten-
ing (FS) was calculated by the formula FS= [(EDD/ESD)/
EDD]x100, where EDD means left ventricular end-diastolic
dimension and ESD left ventricular end-systolic dimension.
Ejection fraction (EF) was assessed by Simpson’s biplane method
at 2-dimensional parasternal long-axis view. All the analyses were
conducted according to the American Society of Echocardiogra-
phy guidelines [29].
Exercise Capacity
Twenty-four hours after echocardiographic assessment, exercise
capacity was measured, which was conducted at baseline (4 weeks
after surgery) and at the end of study (12 weeks after surgery). The
rats were previously adapted to treadmill exercise before testing.
On a treadmill inside of a metabolic chamber coupled to a gas
analyzer, rats ran progressively until exhaustion, starting at
6 m.min21 and 3 m.min21 increments every 3 minutes. Peak
oxygen uptake (peak VO2) was defined as the highest VO2
achieved before exhaustion, calculated by the formula peak
VO2= [(pO2 ambient - pO2 at stage)xF]/m, where pO2 is the
partial oxygen pressure measured in the ambient before testing
and continuously through each stage inside the chamber, F is the
airflow through the chamber (3500 mL.min21), and m is the rat’s
body mass in kilogram, adapted from Brooks and collaborators
[30]. This procedure also provided running distance, in meters.
Exercise Training
Twenty-hour hours after exercise capacity assessment at
baseline, exercise training began. Continuous moderate aerobic
exercise training was conducted on a treadmill for 60 minutes at
60% of peak VO2, 5 days a week for 8 weeks as described earlier
[31]. At the end of the fourth week, training rats underwent
another exercise test to adjust the intensity of exercise training. All
rats kept sedentary were exposed to treadmill running for 5
minutes, once a week, to maintain their running skills.
Sacrifice and Collection of Blood and Tissues
Twenty-four hours after peak V02 assessment at the end of the
experimental protocol, the rats were quickly sacrificed by
decapitation with no prior anesthesia to avoid influences on
RAS cascade. Trunk blood was immediately collected into dry (for
serum) and cooled tubes (for plasma) with proteases inhibitor
cocktail (miniComplete, Roche, USA), separated from total blood
as soon as possible, and frozen for posterior analysis. The tissue
samples were quickly excised, weighted, and frozen in liquid
nitrogen. Thereafter, the samples were stored in a freezer280u for
later analysis.
ACE and ACE2 Activity Assay
ACE activity was determined in serum, and in skeletal soleus
and plantaris muscle by using fluorescent substrates [32]. Frozen
skeletal muscle samples were homogenized in 0.1 M Tris-HCl
buffer pH 7.0, containing 50 mM NaCl and centrifuged at
1,0006g for 10 minutes. The assays were performed at 37uC in
0.1 M Tris-HCl buffer pH 7.0, containing 50 mM NaCl and
10 mM ZnCl2, and captopril 0.5 mL as inhibitor in negative
samples. The hydrolysis rate of the intramolecularly quenched
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fluorogenic substrate Abz-FRK-(Dnp)P-OH (10 uM) incubated
with aliquots of homogenate and serum for 30 minutes at 37uC
was assessed to obtain ACE enzymatic activity (420 nm lem and
320 nm lex, read in 90 cycles). ACE2 activity was determined by
the same method described above. However, Abz-APK(Dnp)-OH
was used as the fluorescent peptide, in 0.2 M Tris-HCl buffer,
200 mM NaCl, pH 7.5, and DX600 1 mM as the inhibitor. ACE
and ACE2 activity are expressed as uF.min21.mg21 of skeletal
muscle protein concentration, or uF.min21.mL21 of serum.
Quantification of Angiotensins
The determination of AngI, AngII, and Ang-(1–7) was
quantified by High Performance Liquid Chromatography
(HPLC), as previously demonstrated by our group [26]. After
centrifugation (10,0006g, 4uC, 20 min), 1 mL of plasma was
filtered in Oasis C18 columns (Waters, USA), previously activated
with methanol (5 mL), tetrahydrofuran (5 mL), hexane (5 mL),
methanol (5 mL), and water (10 mL). After activation, the samples
were applied into the columns, washed with water and eluted in
ethanol/acetic acid/water in the proportion 90%/4%/6%. The
eluted fractions were lyophilized and resuspended in 500 mL of
mobile phase A (5% acetonitrile in 0.1% orthophosphoric acid)
and filtered with 0.22 mm membrane for analysis (HPLC,
Shimadzu System, Japan). The angiotensin of each sample was
separated on a reversed phase column ODS Aquapor 300
(25064.6 mm), 7 m (PerkinElmer’s Browlee Columns, USA) using
the gradient from 5–35% of mobile phase B (95% acetonitrile in
0.1% phosphoric acid) under a flow of 1.5 mL.min21 for 40
minutes. The angiotensins were identified by comparing them
with the retention time of standard angiotensins. Results are
expressed as pmol.mL21 of plasma. Skeletal muscle soleus and
plantaris samples were weighted and homogenized in 100 mM
sodium phosphate buffer pH 7.2, 340 mM sucrose and 300 mM
NaCl and protease inhibitor cocktail (Roche, USA). The samples
were centrifuged and followed the same sequence as described for
plasma angiotensins. Results are expressed as pmol.g21 of tissue.
Quantification of Protein Expression
The protein expression of ACE and ACE2 in the soleus and
plantaris muscles was analyzed using western blot. The frozen
samples were homogenized in cell lyses buffer containing 100 mM
Tris-HCl, 50 mM NaCl, 1% Triton X-100, and protease inhibitor
cocktail (1:100, Sigma-Aldrich, USA). After centrifugation (10,000
6g, 4uC, 10 min), the pellet was discarded, and the samples were
loaded (Laemmli 1:1, Sigma-Aldrich, USA) and underwent SDS-
PAGE in 10% polyacrylamide gels. Equal loading of samples
(30 mg) were applied for electrophoresis, and proteins were electro-
transferred to nitrocellulose membrane (BioRad Biosciences,
USA). The blot membrane was then incubated in a blocking
buffer (5% BSA, 10 mM Tris-HCl, pH 7.6, 150 mM NaCl, and
0.1% Tween 20) for 2 hours at room temperature and then
incubated overnight at 4uC with mouse anti-ACE (ab11734,
1:100, Abcam, USA) and rabbit anti-ACE2 (sc-20998 1:200, Santa
Cruz, USA). Binding of the primary antibody was detected with
the use of peroxidase-conjugated secondary antibodies, and
enhanced chemiluminescence reagents (Amersham Biosciences,
USA) were used to visualize the autoradiography. Quantification
blot analyses were performed using Image-J software (National
Institute of Health, USA), normalized to relative changes in mouse
anti-GAPDH (ab9484, 1:5000, Abcam, USA).
RNA Isolation and mRNA Quantification
Frozen skeletal muscle samples were homogenized in Trizol,
and RNA was isolated according to manufacturer’s instructions
(Invitrogen Life Technologies, USA). Following extraction, total
RNA concentration was quantified using NanoDrop Spectropho-
tometer (Nano-Drop Technologies, USA) and checked for
integrity by EtBr agarose gel electrophoresis. cDNA was
synthetized using reverse transcriptase at 70uC for 10 minutes,
incubation at 42uC for 60 minutes, and 95uC for 10 minutes. The
mRNA expression was assessed by oligonucleotides primers
(Exxtend, Brazil) for analysis of the genes AT1a (Sense: 59-CAC
AAC CCT CCC AGA AAG TG-39; antisense:59-AGG GCC
Figure 1. Experimental protocol.
doi:10.1371/journal.pone.0098012.g001
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ATT TTG TTT TTC TG-39), AT2 (Sense: 59- GAA CAG AAT
TAC CCG TGA CC-39; antisense: 59- ATG AAT GCC AAC
ACA ACA GC-39), Mas (Sense: 59-GAC CAG CCC ACA GTT
ACC AGT T-39; antisense:59- CCA GGG TTC CCC TTC TGA
CT-39) and reference gene Ciclophilin (Sense: 59- TGG CAA
GCA TGT TGG GTC TTT GGG AAG-39; antisense: 59-GGT
GAT CTT CTT GCT GCT CTG CCA TTC-39). Real-time
PCRs were run separately, and amplifications were performed by
ABI Prism 5700 Sequence Detection System (Applied Biosystems,
USA) by using SYBR Green PCR Master Mix (Applied
Biosystems, USA). Results were quantified as Ct values, where
Ct is defined as the threshold cycle of the polymerase chain
reaction at which the amplified product is first detected. Each
sample was analyzed in duplicate. Relative quantities of target
gene expressions of four groups were compared after normaliza-
tion to the values of the reference gene (DCT). Fold changes in
mRNA expression were calculated using the differences in DCT
values between the two samples (DDCT) and the equation 2-
DDCT. Results are expressed in percentages of control (Sham-S).
Statistical Analysis
Results are presented as mean6SEM. The Student t test was
conducted to compare infarcted and Sham rats 4 weeks after
surgery and, hence, ascertain for CHF. At the end of the protocol
(12 weeks after surgery), the groups were compared by 2-way
ANOVA (exercise training and CHF as the main factors), with
Scheffe´ test for post hoc comparisons. P value # 0.05 was accepted
as significant.
Results
Baseline Measures
Four weeks after surgery, body weight was not significantly
different between CHF and Sham rats (386615 vs. 377611.7 g).
Left ventricular end-diastolic diameter (EDD), end-systolic diam-
eter (ESD), fractional shortening (FS), and ejection fraction (EF)
were significantly lower in CHF rats compared with that of Sham
rats, consistent with cardiac remodeling associated with dilation
and dysfunction (Table 1). Functional capacity, expressed by peak
VO2, and running distance were lower in the CHF rats, indicating
exercise intolerance (Table 1). At this point, the rats were divided
into sedentary and exercise-trained groups.
Effects of Exercise Training on Functional Capacity and
Cardiac Function
Physiological parameters in untrained and exercised-trained
Sham and CHF rats are shown in Table 2. There were no
significant differences in body weight among groups. The heart
and right ventricle mass were significantly increased in CHF rats,
and exercise training caused no changes in these parameters
(Table 2). Exercise training did not significantly change echocar-
diographic parameters or peak VO2 in CHF rats. However,
exercise training significantly increased running distance in both
Sham-operated and CHF rats but caused no change in FS (Fig. 2).
Effects of Exercise Training on Circulating RAS
CHF did not change serum ACE activity, but caused a 25%
reduction in ACE2 activity (Fig. 3, P=0.04). Exercise training
significantly decreased ACE activity in the CHF rats (P=0.05),
and restored the ACE2 activity towards the levels found in Sham-
operated rats (Fig. 3). No significant changes in ACE and ACE2
activity occurred in the Sham-Ex. In regard to plasma angioten-
sins, we found no significant changes in plasma AngII levels in
CHF rats. Exercise training provoked a significant reduction in
AngII levels in both Sham (33%, P=0.03) and CHF rats (43%,
P=0.007) (Fig. 3). Plasma AngI and Ang-(1–7) were unchanged by
CHF or exercise training (Table 3 and Fig. 3). However, exercise
training significantly increased the Ang-(1–7)/AngII ratio in CHF
rats (Fig. 3). No changes were found in the Sham-Ex.
Effects of Exercise Training on RAS in the Soleus Muscle
CHF or exercise training did not change ACE activity and
protein expression in soleus muscle (Fig. 4). CHF provoked a 2.1-
fold increase in AngII concentration in the soleus muscle
(P=0.001), and exercise training decreased it to the normal levels
(Fig. 5). There were no significant differences in AngI among
groups (Table 3). The AT1 receptor gene expression in the soleus
muscle was significantly increased in CHF rats (P=0.04, Fig. 6).
Exercise training normalized these levels. AT2 gene expression
was not different among groups. Similarly, no changes in Ang-(1–
7) concentration were found among groups (Fig. 5). Exercise
training tended to increase Ang-(1–7)/AngII ratio in Sham-
operated (P=0.06) and CHF (P=0.08) rats (Fig. 5). Exercise
training increased Mas gene expression in both Sham and CHF
rats (P=0.02) (Fig. 6).
Effects of Exercise Training on RAS in Plantaris Muscle
In regard to plantaris muscle, CHF and exercise training
unchanged ACE activity and protein expression (Fig. 7). In
contrast, AngI and AngII in the plantaris muscle were 1.5- and
2.5-fold increased of CHF rats (Table 3, Fig. 8). CHF and exercise
training did not change AT1 or AT2 receptors (Fig. 9). Exercise
training decreased AngI and AngII towards normal levels (Table 3,
Fig. 8). Exercise training significantly increased Ang-(1–7), but
caused no significant changes in Ang-(1–7)/AngII ratio (Fig. 8).
There were no differences in ACE2 activity or protein expression
Table 1. Echocardiographic characteristics and functional capacity of the animals 4 weeks after surgery.
Sham CHF P
EDD (mm) 7.3660.16 9.9260.22 ,0.0001
ESD (mm) 4.0160.20 9.7560.45 ,0.0001
FS (%) 46.8961.78 11.9761.00 ,0.0001
EF (%) 80.7062.46 28.7562.18 ,0.0001
Peak VO2 (mL.kg
21.min21) 68.9062.55 59.5961.90 0.005
Running distance (m) 390.49623.61 276.49615.59 ,0.0001
CHF, Chronic heart failure; EDD, End-diastolic diameter; ESD, End-systolic diameter; FS, fractional shortening; EF, ejection fraction.
doi:10.1371/journal.pone.0098012.t001
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among groups (Fig. 7). Exercise training significantly reduced the
Mas gene expression in CHF (Fig. 9).
Discussion
The main and new findings of the present study are that
exercise training in an ischemic model of CHF: 1) Normalizes
AngII concentration in soleus and plantaris muscle; 2) Decreases
AT1 receptors towards normal levels in soleus muscle; 3) Increases
Ang-(1–7)/AngII ratio in plasma and soleus; and 4) Increases Mas
receptor mRNA expression in soleus muscle.
Our study confirms previous studies [10,25] that demonstrated
that exercise training causes remarkable changes in circulating
RAS in CHF. The reduction in circulating ACE activity and
AngII concentration in CHF rats has important implications.
Firstly, the improvement in arterial baroreflex control of renal
sympathetic nerve activity in CHF rats depends on the reduction
in plasma AngII [31]. Mousa and collaborators [10] elegantly
demonstrated that administration of AngII to maintain its levels
near those found in untrained CHF restrained the amelioration in
arterial baroreflex sensitivity in exercise-trained CHF rabbits.
Secondly, AngII increases sympathetic nerve activity [10,33]. This
knowledge may predict that exercise training decreased sympa-
thetic outflow in our study. In fact, sympathetic deactivation has
been consistently reported after exercise training in CHF
[10,23,31]. Thirdly, both the improvement in baroreflex sensitivity
and the reduction in sympathetic activity are associated with better
prognosis in CHF [34,35].
In CHF patients, there is an association between serum ACE2
and the severity of this syndrome [36]. A possible explanation for
this response is that AngII provokes ACE2 shedding mediated by
TACE/ADAM-17, which increases serum ACE2 activity [37]. In
conformity to a previous study on the same experimental model
[38], we found that serum ACE2 activity was reduced in CHF.
The contrast between serum ACE2 in humans with CHF and the
experimental model of CHF is not clear. However, it could be
speculated that the pharmacological inhibition of ACE usually
prescribed for humans with CHF causes a compensatory increase
in serum ACE2 activity. In fact, some investigators have previously
observed an association between serum ACE inhibition and ACE2
increase [39]. Exercise training significantly decreased serum ACE
activity and increased serum ACE2 activity. This finding
reinforces the inverse association between ACE and ACE2
activity.
Despite the fact that exercise training increases serum ACE2
activity towards normal levels, no significant changes in circulating
Ang-(1–7) concentration were found. Since AngII is the major
substrate for the production of Ang-(1–7), it is possible to
anticipate that the reduction in AngII concentration limited the
formation of Ang-(1–7). All together, these findings indicate that
exercise training causes a switch in circulating ACE-AngII towards
an increase in ACE2-Ang-(1–7) axis in CHF rats, which may
render the cardiovascular system less susceptible to the deleterious
actions of AngII [40].
We hypothesized that exercise training would cause a shift in
RAS in skeletal muscle towards the ACE2-Ang-(1–7)-Mas axis.
Figure 2. Ventricular function and exercise capacity in sedentary and exercise-trained Sham and CHF rats. CHF, chronic heart failure; -S,
Sedentary; -Ex, Exercise-trained. A, Fractional shortening (FS); B, Running distance in Sham and CHF, sedentary and trained rats, 12 week after surgery.
*P,0.05 vs. Sham-S; {P,0.05 vs. CHF-S.
doi:10.1371/journal.pone.0098012.g002
Table 2. Physiological parameters in sedentary and exercised-trained Sham-operated and CHF rats.
Sham-S Sham-Ex CHF-S CHF-Ex
Body weight (g) 452.13611.96 424.9767.93 451.83617.21 423.59613.47
Heart (g) 1.1260.04 1.1060.03 1.4660.07* 1.5260.06*
RV (g) 0.2360.01 0.2360.01 0.4260.05* 0.4360.02*
EDD (mm) 7.2460.24 7.7060.21 11.5560.32* 11.3060.32*
ESD (mm) 3.7260.25 4.5460.19 10.1360.36* 9.4360.60*
EF (%) 81.8362.73 79.9261.42 29.7362.69* 28.3763.18*
Peak VO2 (mL.kg
21.min21) 65.8662.24 73.9662.39* 55.9962.62 62.2162.58
CHF, chronic heart failure; -S, Sedentary; -Ex, Exercise-trained; RV, right ventricle mass; EDD, End-diastolic diameter; ESD, End-systolic diameter; EF, left ventricular
ejection fraction.
*P,0.05 vs. Sham-S.
doi:10.1371/journal.pone.0098012.t002
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Our findings confirm in great part this hypothesis. Exercise
training decreased AngII in both soleus and plantaris muscle in the
ischemic model of CHF. In addition, exercise training tended to
increase the Ang-(1–7)/AngII ratio, which suggests an imbalance
in the RAS towards the ACE2-Ang-(1–7)-Mas receptor axis. The
reduction in the AngII concentration and AT1 receptor gene
expression in skeletal muscle is an important issue. Previous studies
show that AngII is involved in inflammation and oxidative stress
[13,41]. These alterations contribute to muscle catabolism and
apoptosis in CHF [12–14,42,43]. Our study provides no
information on muscle protein synthesis and degradation. Future
investigations should focus on the contribution of ACE-AngII-
AT1 receptor axis in the amelioration in skeletal myopathy.
The mechanisms by which exercise training decreased AngII
concentration in skeletal muscle in CHF rats is out of the scope of
the present study. However, it is possible that exercise training
reduced AngII uptake in the soleus muscle [44], because AT1
expression was substantially lower in the exercise-trained rats. In
plantaris muscle, exercise training also reduced AngII concentra-
tion, but caused no changes in AT1 expression. These findings
raise the question that the mechanisms underlying the reduction in
AngII in plantaris muscle and soleus muscle are different.
Someone could suggest that the reduction in AngII in the plantar
muscle is due to the decrease in AngI cleavage. In fact, we found
that AngI concentration in plantar muscle was significantly lower
in exercise-trained CHF compared to that in untrained CHF rats.
Our data clearly demonstrate that there is a mismatch between
circulating and skeletal muscle RAS. Elevation in AngII concen-
tration was found in the skeletal muscle, but not in the circulation.
These findings are consistent with those of previous studies that
show that local RAS becomes activated in tissues in CHF [5–8].
The increase in the plasma AngII concentration seems to occur
Figure 3. Circulating renin angiotensin system (RAS) in sedentary and exercise-trained Sham and CHF rats. CHF, chronic heart failure;
-S, Sedentary; -Ex, Exercise-trained. A, Angiotensin II; B, Angiotensin-(1–7); C, Ang-(1–7)/AngII ratio; D, ACE activity; E, ACE2 activity. *P,0.05 vs. Sham-
S; {P,0.05 vs. CHF-S.
doi:10.1371/journal.pone.0098012.g003
Table 3. Plasma and skeletal muscle AngI in sedentary and exercise-trained Sham-operated and CHF rats.
Sham-S Sham-Ex CHF-S CHF-Ex
Plasma AngI (pmol.mL21) 88.7968.22 75.0069.73 97.76612.17 70.40612.25
Soleus AngI (pmol.g21) 39.1869.68 28.5062.96 59.79616.98 46.4668.44
PlantarisAngI (pmol.g21) 49.1969.01 38.88611.76 67.70614.90* 39.9465.74{
CHF, chronic heart failure; -S, Sedentary; -Ex, Exercise-trained; AngI, Angiotensin I.
*P,0.05 vs. Sham-S;
{P,0.05 vs. CHF-S.
doi:10.1371/journal.pone.0098012.t003
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Figure 4. Soleus muscle ACE and ACE2 in sedentary and exercise-trained Sham and CHF rats. CHF, chronic heart failure; -S, Sedentary;
-Ex, Exercise-trained; ACE, Angiotensin Converting Enzyme. A, ACE activity; B, ACE2 activity; C, ACE protein expression; D, ACE2 protein expression.
doi:10.1371/journal.pone.0098012.g004
Figure 5. Soleus muscle angiotensins in sedentary and exercise-trained Sham and CHF rats. CHF, chronic heart failure; -S, Sedentary; -Ex,
Exercise-trained. A, Angiotensin II; B, Angiotensin-(1–7); C, Ang-(1–7)/AngII ratio. *P,0.05 vs. Sham-S.
doi:10.1371/journal.pone.0098012.g005
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only in the late stage of CHF [3,4]. ACE was not altered in the
skeletal muscle, which suggests alternative local pathways of AngII
production involving other enzymes as Prolyl-endopeptidase,
Neprilysin and Chymase [45–47], especially in the plantaris
muscle. Exercise training reduced AngII concentration in both
plasma and skeletal muscle. Exercise training reduces ACE and
Figure 6. Soleus muscle angiotensin receptors in sedentary and exercise-trained Sham and CHF rats. CHF, chronic heart failure; -S,
Sedentary; -Ex, Exercise-trained. A, AT1 mRNA gene expression; B, AT2 mRNA gene expression; C, Mas mRNA gene expression. *P,0.05 vs. Sham-S.
doi:10.1371/journal.pone.0098012.g006
Figure 7. Plantaris muscle ACE and ACE2 in sedentary and exercise-trained Sham and CHF rats. CHF, chronic heart failure; -S, Sedentary;
-Ex, Exercise-trained; ACE, Angiotensin Converting Enzyme. A, ACE activity; B, ACE2 activity; C, ACE protein expression; D, ACE2 protein expression.
doi:10.1371/journal.pone.0098012.g007
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restores ACE2 activity in the circulation, without changing ACE
and ACE2 activity or protein expression in skeletal muscle. Other
investigators reported that electric stimulated C2C12, a strategy to
mimic in vitro exercise effects, caused no changes in skeletal muscle
ACE gene expression [48].
Previous studies demonstrated that the AT1 receptor was
increased in the vasculature of patients with ischemic heart disease
[49], and in local tissues in experimental models of CHF [5,7,10].
In our study, we found increased AT1 receptor mRNA in soleus
muscle in CHF rats. This increase in AT1 receptors may be
associated with elevation in sympathetic nerve activity. In a
previous study, isoproterenol administration increased AT1
receptor expression [50]. Exercise training reverted AT1 receptor
gene expression towards normal levels, which may be linked to
reduction in sympathetic activation. We and others have
Figure 8. Plantaris muscle angiotensins in sedentary and exercise-trained Sham and CHF rats. CHF, chronic heart failure; -S, Sedentary;
-Ex, Exercise-trained. A, Angiotensin II; B, Angiotensin-(1–7); C, Ang-(1–7)/AngII ratio. *P,0.05 vs. Sham-S.
doi:10.1371/journal.pone.0098012.g008
Figure 9. Plantaris muscle angiotensin receptors in sedentary and exercise-trained Sham and CHF rats. CHF, chronic heart failure; -S,
Sedentary; -Ex, Exercise-trained. A, AT1 mRNA gene expression; B, AT2 mRNA gene expression; C, Mas mRNA gene expression. *P,0.05 vs. Sham-S.
doi:10.1371/journal.pone.0098012.g009
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consistently found a reduction in sympathetic nerve activity in
heart failure [10,23,31].
We found no changes in AT2 receptors in our study. The AT2
gene expression in both soleus and plantar muscles was not altered
in CHF rats. Similar findings have been reported in patients with
heart failure. Some investigators found no AT2 gene expression in
skeletal muscle in patients with CHF [51]. In our study, exercise
training caused no changes in AT2 receptors in either normal
controls or CHF rats.
Our study demonstrates for the first time that exercise training
changes the Ang-(1–7) and Ang-(1–7)/AngII ratio and Mas
receptor expression in skeletal muscle in CHF rats. These are
remarkable effects provoked by exercise training. Ang-(1–7) is a
potent vasodilator as are other interventions in the treatment of
heart failure, and in the muscle level, Ang-(1–7)/Mas improves
insulin sensitivity by increasing Akt phosphorilation [19].
Limitations
We recognize limitations in our study. We only studied mRNA
expression of angiotensin receptors. Thus, someone could argue
that there is no guarantee that the changes in gene expression have
been translated into protein expression. Our study provides no
direct information regarding the implications of RAS modifica-
tions in the function of skeletal muscle. The increase in running
distance is suggestive of improvement in functional capacity, but
not sufficient to demonstrate amelioration in skeletal muscle
function.
Perspectives
The antagonism of the RAS and sympathetic outflow is the
target in the treatment of heart failure. The present study shows
that exercise training provokes profound changes in circulating
and skeletal muscle RAS. The switch from AngII/AT1 to Ang-(1–
7)/Mas axis in the skeletal muscle may have implications in the
skeletal myopathy in heart failure. Growing evidence shows that
AngII is involved in the skeletal muscle pathophysiology of heart
failure. Finally, these findings strengthen the recommendation of
exercise training in the treatment of CHF.
In conclusion, exercise training improves RAS in the Ang-(1–7)-
Mas axis in skeletal muscle. This effect of exercise training seems
to depend on skeletal muscle metabolic characteristics. The
changes in circulating RAS do not necessarily reflect the changes
occurring in skeletal muscle RAS.
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